Dysregulation of miR-124 has been reported to be involved in the pathophysiology of depression. Chaihu-Shugan-San, a traditional Chinese medicine, has antidepressive activity; however, the underlying mechanisms remain unclear. In this study, to generate a rodent model of depression, rats were subjected to a combination of solitary confinement and chronic unpredictable mild stress for 28 days. Rats were intragastrically administered Chaihu-Shugan-San (2.835 mL/kg/d) for 4 weeks, once a day. Real-time reverse-transcription quantitative polymerase chain reaction, miRNA microarray, western blot assay and transmission electron microscopy demonstrated that Chaihu-Shugan-San downregulated miR-124 expression and upregulated the mRNA and protein levels of mitogen-activated protein kinase 14 (MAPK14) and glutamate receptor subunit 3 (Gria3). Chaihu-Shugan-San also promoted synapse formation in the hippocampus. The open field test, sucrose consumption test and forced swimming test were used to assess depression-like behavior. After intragastric administration of Chaihu-Shugan-San, sucrose consumption increased, while the depressive behaviors were substantially reduced. Together, these findings suggest that Chaihu-Shugan-San exerts an antidepressant-like effect by downregulating miR-124 expression and by releasing the inhibition of the MAPK14 and Gria3 signaling pathways.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998613 | PMC |
| http://dx.doi.org/10.4103/1673-5374.232478 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
miR-124, miR-126-3p, and miR-200b: Potential therapeutic targets for VEGF-mediated complications in proliferative diabetic retinopathy.
Indian J Ophthalmol
December 2024
Department of Biochemistry, Trakya University School of Pharmacy, Edirne, Turkey.
Introduction: This study aimed to investigate alterations in intravitreal microRNA and vascular endothelial growth factor (VEGF) levels in patients with proliferative diabetic retinopathy (PDR) as these factors are implicated in PDR pathogenesis.
Methods: Fifty-two participants, including 26 patients with PDR and 26 controls without diabetes, were included in this study. VEGF levels were assessed using ELISA, and seven microRNAs (miRNAs) (miR-19a, miR-20b, miR-27a, miR-124, miR-126-3p, miR-146a, and miR-200b) were analyzed using quantitative real-time PCR.
Evaluation of tumorigenesis-related miRNAs in breast cancer in Egyptian women: a retrospective, exploratory analysis.
Sci Rep
November 2024
Department of Microbial Biotechnology, Biotechnology Research Institute, National Research Centre, EL Bohouth St. (Former El Tahrir St.), Dokki, P.O. 12622, Giza, Egypt.
Breast cancer (BC) is a leading cause of global female cancer-related deaths, despite treatment advancements. A growing focus on investigating microRNA-based therapeutics and their role in BC progression. A computational analysis was performed to identify the potential miRNA-mRNA network involved in the BC pathogenesis and assist with the treatment strategy.
View Article and Find Full Text PDFHigh expression of SLC34A2 contributes to chemoresistance of non-small cell lung cancer against gefitinib: The critical role of miR-124-3p.
Mutat Res
November 2024
Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443003, China; Yichang Central Blood Station, Yichang 443003, China. Electronic address:
Article Synopsis
- Gefitinib is a treatment for non-small cell lung cancer (NSCLC), but many cells become resistant to it, which isn't fully understood.
- This study found that low levels of miR-124-3p and high levels of SLC34A2 are associated with gefitinib resistance in NSCLC cells.
- Increasing miR-124-3p reduced resistance to gefitinib, while increasing SLC34A2 made resistance worse, suggesting a critical interaction between these two factors in NSCLC treatment outcomes.
Circulatory microRNAs and proinflammatory cytokines as predictors of lupus nephritis.
Front Immunol
October 2024
Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Introduction: Lupus nephritis (LN) is one of the most prevalent severe organ manifestations of systemic lupus erythematosus (SLE), impacting 70% of SLE patients. MicroRNAs (miRNAs), are small non-coding RNA molecules which influence the expression of approximately one-third of human genes after the process of transcription. Dysregulation of miRNAs was documented in numerous disorders, including SLE and LN.
View Article and Find Full Text PDFStage-specific expression patterns and co-targeting relationships among miRNAs in the developing mouse cerebral cortex.
Commun Biol
October 2024
Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Article Synopsis
- MicroRNAs (miRNAs) play a key role in brain development but their regulatory networks are not well understood, prompting researchers to study them in mouse embryonic cortex at various stages.
- Through small RNA sequencing, specific clusters of co-regulated miRNAs were identified, with certain miRNAs acting as central players during early and late neurogenesis.
- The research also revealed that combinations of miRNAs can enhance gene silencing, providing insights into how miRNA networks influence factors essential for neuronal differentiation and overall brain development.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!